CXCL9 and lymphoma: reported a downregulation of the C-X-C motif chemokine ligand 9 (CXCL9) gene in patients with AIGAs, and CXCL9 served as a dependable biomarker to distinguish lymphadenopathy associated with AIGAs, which mimicked lymphoma (32).